Cargando…
The Future of Seed Amplification Assays and Clinical Trials
Prion-like seeded misfolding of host proteins is the leading hypothesised cause of neurodegenerative diseases. The exploitation of the mechanism in the protein misfolding cyclic amplification (PMCA) and real-time quaking-induced conversion (RT-QuIC) assays have transformed prion disease research and...
Autores principales: | Coysh, Thomas, Mead, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257179/ https://www.ncbi.nlm.nih.gov/pubmed/35813946 http://dx.doi.org/10.3389/fnagi.2022.872629 |
Ejemplares similares
-
Two simple assays for assessing the seeding activity of proteopathic tau
por: Liu, Fei, et al.
Publicado: (2023) -
Editorial: Utility of protein aggregation assays from laboratory to clinical application
por: Green, Alison Jane Ellen
Publicado: (2022) -
Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification
por: Peden, Alexander H., et al.
Publicado: (2021) -
A Roadmap for Future Parkinson's Pharmacogenomics in Asia
por: Akbar, Muhammad, et al.
Publicado: (2022) -
Corrigendum: Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
por: He, Joy Q., et al.
Publicado: (2022)